Dr. Kuan Chee Sian
Managing Director

Bsc (Hons) Biomedical Science (USM)
PhD in Molecular and Cellular Biology (USM)

Dr Kuan is the founder and Managing Director of NeoGenix Laboratoire Sdn Bhd and NeoGenix Evo Sdn Bhd. He is also medical advisor of The Malaysian Cancer Foundation. He has in-depth experience in business management, laboratory set-ups as well as R&D in life sciences. He has written 30 international medical sciences articles.

​

He actively collaborates with pharmaceutical and diagnostics industries to evaluate for more than 30 molecular diagnostic assays and develop an Integrated Fungal Genome Database and Taxonomic Engine. He lead NeoGenix Laboratoire Sdn. Bhd. to get the "Excellent Lab Analysis" award by National Consumer Action Council in 2019.

​

He is also active in a business association as he is the ex-President and ex-Vice President in the Business Network International (BNI) KLCC, Allegro Chapter and Launch Ambassador of BNI Malaysia that launched Professional Chapter in KLCC.

Joveen Neoh Wan Fen
Operation Director/
Quality Manager

Bachelor of Science (Conservation Biology)
Msc in Molecular Biology (UMS)

Joveen is responsible to review overall operations which has been geared for growth rather than efficiency and productivity. She has many years’ experience in Malaria diagnostic & examination studies.

​

Joveen also has more than 5 years’ experience of Next Generation Sequencing (NGS) and microarray in genetic and genomics research. She is the one who involved in the entire start up and overall management of R&D department and actively collaborates with both private and government sectors.

​

As a Quality Manager, she led in successful implementation of ISO 15189 accreditation with Standards Malaysia.

Dr. Yew Su Mei
Laboratory Director

Bsc (Hons) Microbiology (UKM)
Master of Science (Forensic Science)
PhD in Medical Microbiology (UM)

Dr Yew is the Head of Department in Molecular Diagnostic Department. She managed the construction and commissioning of NeoGenix main lab in 2016 and implement an automation system for COVID-19 testing.

​

She was instrumental in building up the current team and executing the rollout of infrastructure and building out the processes and procedures to ensure efficiency and effectiveness. Her focus was on fungal genomics and infectious diseases surveillance studies and published 22 international articles.

​

Her effort enabled a service level that ensured the sales & marketing team was able to effectively ramp up revenue so that the start-up was EBITDA positive.